SpineGuard SA (EPA: ALSGD)
France
· Delayed Price · Currency is EUR 0.215
-0.003 (-1.15%)
Nov 20, 2024, 5:35 PM CET
SpineGuard Revenue
SpineGuard had revenue of 2.45M EUR in the half year ending June 30, 2024, a decrease of -3.94%. This brings the company's revenue in the last twelve months to 4.52M, down -14.43% year-over-year. In the year 2023, SpineGuard had annual revenue of 4.31M, down -22.98%.
Revenue (ttm)
4.52M
Revenue Growth
-14.43%
P/S Ratio
1.99
Revenue / Employee
188.52K
Employees
22
Market Cap
10.96M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.31M | -1.29M | -22.98% |
| Dec 31, 2022 | 5.60M | 1.19M | 27.11% |
| Dec 31, 2021 | 4.41M | -446.53K | -9.20% |
| Dec 31, 2020 | 4.85M | -1.98M | -28.95% |
| Dec 31, 2019 | 6.83M | -746.48K | -9.85% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 48.45B |
| EssilorLuxottica Société anonyme | 25.83B |
| Sartorius Stedim Biotech S.A. | 2.74B |
| bioMérieux S.A. | 3.81B |
| Eurofins Scientific SE | 6.72B |
| Ipsen S.A. | 3.44B |
| Virbac SA | 1.34B |
| Ramsay Générale de Santé SA | 5.01B |